Bedel Financial Consulting’s Regeneron Pharmaceuticals REGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q2
Sell
-15
Closed -$10K 725
2022
Q1
$10K Hold
15
﹤0.01% 675
2021
Q4
$9K Hold
15
﹤0.01% 701
2021
Q3
$9K Hold
15
﹤0.01% 694
2021
Q2
$8K Hold
15
﹤0.01% 708
2021
Q1
$7K Hold
15
﹤0.01% 696
2020
Q4
$7K Hold
15
﹤0.01% 609
2020
Q3
$8K Sell
15
-5
-25% -$3.03K ﹤0.01% 547
2020
Q2
$12K Hold
20
0.01% 468
2020
Q1
$10K Buy
20
+5
+33% +$2.06K 0.01% 480
2019
Q4
$6K Sell
15
-24
-62% -$8.07K ﹤0.01% 566
2019
Q3
$11K Hold
39
0.01% 472
2019
Q2
$12K Hold
39
0.01% 467
2019
Q1
$16K Hold
39
0.01% 418
2018
Q4
$15K Hold
39
0.01% 403
2018
Q3
$15K Hold
39
0.01% 423
2018
Q2
$13K Buy
39
+24
+160% +$7.51K 0.01% 447
2018
Q1
$5K Buy
+15
New +$5.22K ﹤0.01% 543

Other funds holding REGN